Kilpest India Ltd gets approval from ICMR for TRURAPID® COVID-19 Ag Test

Kilpest India Ltd has announced that finally after extensive efforts our "TRURAPID® COVID-19 Ag Test" has been approved by ICMR (Indian Council of Medical Research) on February 2, 2022.

Now the company will try to build this product assuming that COVID testing will continue depending on the disease progression with time.

Although the prices for Rapid Antigen Test for COVID have dropped to a very low level, still the company will do its efforts.

Shares of KILPEST INDIA LTD. was last trading in BSE at Rs. 439.70 as compared to the previous close of Rs. 440.20. The total number of shares traded during the day was 10614 in over 455 trades.

The stock hit an intraday high of Rs. 441.35 and intraday low of 431.00. The net turnover during the day was Rs. 4635825.00.

Source : Equity Bulls

Keywords

KILPESTINDIA INE994E01018 ICMR Approval Covid19 AgTest